Publications in 2014

  1. A.V. Ivachtchenko, P.M. Yamanushkin, O.D. Mitkin, E.V. Yezhova, O.M. Korzinov, N.A. Shevkun, R.P.Karapetyan, V.V. Bychko, A.A. Ivachtchenko, V.Z. Agra, B.A. Lapin, S.V. Orlov, IE Kuznetsov. Preclinical safety studies of new pharmacological substances AV0012 to treat hepatitis C. Experimental and Clinical Pharmacology, 2014, 77 (12), 33-37.

  2. A.V. Ivachtchenko, E.S. Golovina, M.G. Kadieva, O.D. Mitkin, I.M. Okun. Antagonists of serotonin receptor subtype 5-HT6. VI. The synthesis and structure-activity relationship of substituted 3- (phenylsulfonyl) quinoline. J. Chem-Pharm., 2014, 48, (10), 14-28.

  3. A.V. Ivachtchenko, P.M. Yamanushkin, O.D. Mitkin, E.V. Yezhova, O.M. Korzinov, Е. А. Bulanova, A.G. Koryakova, P.V. Vyshemirskaya, V.V. Bychko, A.A. Ivachtchenko. Activity in vitro and pharmacokinetics inhibitor early stages of viral infection HCV (AVR-560). Experimental and Clinical Pharmacology, 2014, 77 (10), 38-43.

  4. A.V. Ivachtchenko, P.M. Yamanushkin, O.D. Mitkin, V.M. Kisil, O.M. Korzinov, V.Y. Vedensky, I.A. Leneva, E.A. Bulanova, V.V. Bychko, I.M. Okun, A.A. Ivachtchenko, Y.A. Ivanenkov. Synthesis and antiviral activity of substituted ethyl ethers of 2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic acids and their derivatives. J. Chem-Pharm., 2014, 48, (9), 7-19.

  5. A. V. Ivachtchenko, O. D. Mitkin, P. M. Yamanushkin, I. V. Kuznetsova, E. A. Bulanova, N. A., Shevkun, A. G. Koryakova, R. N. Karapetian, V. V. Bichko, A. S. Trifelenkov, D. V. Kravchenko, N. V. Vostokova, M. S. Veselov, N. V. Chufarova, Y. A. Ivanenkov. Discovery of Novel Highly Potent Hepatitis C Virus NS5A Inhibitor (AV4025). J. Med. Chem. 2014, 57, 7716−7730 DOI: 10.1021/jm500951r.

  6. A.V. Ivachtchenko, P.M. Yamanushkin, O.D. Mitkin, O.M. Korzinov, N.A. Shevkun, R.P.Karapetyan, A.A. Ivachtchenko. Study ethyl ether of dihydrochloride 2- (dimethylaminomethyl) -1-methyl-6- (pyridin-3-yl) -1 H-indole-3-carboxylic acid having anti-influenza effect. Experimental and Clinical Pharmacology, 2014, 77 (5), 23-27.

  7. A.V. Ivachtchenko P.M., Yamanushkin O.D., Mitkin, V.M. E.V., Yezhova O.M., Korzinov N.A., Shevkun R.P., Karapetyan V.V., Bychko A.A., Ivachtchenko V.Z., Agra B.A., Lapin S.V., Orlov V. Preclinical study AV0012 – inhibitor early stages of viral hepatitis infections C in vitro. ADME and pharmacokinetics. Experimental and Clinical Pharmacology, 2014, 77 (4), 33-41.

  8. Ivachtchenko A.V. Sulfonyl containing modulators of serotonin 5-HT6 receptor (5-NT6R) and pharmacophore model (Review). Russian Chemical Reviews, 2014, 83 (5), 439-473.

  9. Ivachtchenko A.V., Ivanenkov Y.A., Mitkin O.D., Yamanushkin P.M., Bichko V.V., Shevkun N.A., Karapetian R.N., Leneva I.A., Borisova O.V., Veselov M.S. Novel oral anti-influenza drug candidate AV5080. J. Antimicrob. Chemother. 2014, 69(7), 1892-902.

  10. Ivachtchenko A.V., Mitkin O.D., Kudan E.V., Rjahovsky A.A., Vorobiev A.A., Trifelenkov A.S., Shevkun N.A., Proskurina O.V., Kravchenko D.V., Karapetian R.N. Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment. J. Cancer. 2014, 5(2), 133-142.

  11. Yan A.Ivanenkov, Alexander G. Magouga, Mark S. Veselov, et al. Design and Synthesis of “Recognition Element” Mimetics Targeting PPI. Drug Discovery Chemistry, San Diego, CA, USA, 2014.

  12. Ivashchenko A.V., Ivanenkov Y.A., Veselov M.S., et al. The new neuraminidase inhibitors of influenza virus. Interdisciplinary Symposium on Medical, Organic and Biological chemistry, 2014. Pos. New World.

  13. Ivashchenko A.V., Ivanenkov Y.A. Synthesis, molecular docking and activity of new inhibitors of hepatitis C virus NS5A. Interdisciplinary Symposium on Medical, Organic and Biological chemistry, 2014. Pos. New World.

  14. 30. Andrey Alexandrov. Creating a computer model to predict the toxicity of small molecules. Phystech BIO, 2014.

  15. 31. S.S.Baranovsky N.V.Chufarova M.S.Veselov The novel derivatives of Dimebon – Multimodal potential drug compounds. Phystech BIO, 2014.